{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T05:07:00Z","timestamp":1790917620002,"version":"4.1.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2004]]},"DOI":"10.1007\/s10156-004-0348-9","type":"journal-article","created":{"date-parts":[[2004,12,21]],"date-time":"2004-12-21T14:20:47Z","timestamp":1103638847000},"page":"307-315","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":231,"title":["Challenges and new discoveries in the treatment of leishmaniasis"],"prefix":"10.1016","volume":"10","author":[{"given":"Sarman","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramu","family":"Sivakumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s10156-004-0348-9_bib0005","unstructured":"Geographical distribution of leishmaniasis. Geneva: WHO. Available at: http:\/\/www.who.int\/emc\/diseases\/leish\/leisgeo.html."},{"issue":"9185","key":"10.1007\/s10156-004-0348-9_bib0010","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0140-6736(98)10178-2","article-title":"Leishmaniasis","volume":"354","author":"Herwaldt","year":"1999","journal-title":"Lancet"},{"key":"10.1007\/s10156-004-0348-9_bib0015","first-page":"27","volume":"793","year":"1990"},{"issue":"suppl","key":"10.1007\/s10156-004-0348-9_bib0020","first-page":"1","article-title":"The treatment of kala-azar: new approach to an old problem","volume":"73","author":"Peter","year":"1981","journal-title":"Ind J Med Res"},{"key":"10.1007\/s10156-004-0348-9_bib0025","series-title":"Leishmaniasis","first-page":"443","article-title":"Leishmaniasis in the Indian subcontinent","author":"Sanyal","year":"1985"},{"key":"10.1007\/s10156-004-0348-9_bib0030","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/0035-9203(84)90131-7","article-title":"Epidemiological, clinical and therapeutic features of Bihar kala-azar (including post kala-azar dermal leishmaniasis)","volume":"78","author":"Thakur","year":"1984","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1007\/s10156-004-0348-9_bib0035","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1365-4362.1995.tb03584.x","article-title":"Post-kala-azar dermal leishmaniasis","volume":"34","author":"Ramesh","year":"1995","journal-title":"Int J Dermatol"},{"key":"10.1007\/s10156-004-0348-9_bib0040","doi-asserted-by":"crossref","first-page":"39","DOI":"10.4103\/0022-3859.929","article-title":"Leishmaniasis in HIV infection","volume":"49","author":"Paredes","year":"2003","journal-title":"J Postgrad Med"},{"key":"10.1007\/s10156-004-0348-9_bib0045","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1046\/j.1537-2995.1996.36996420769.x","article-title":"Transfusion-transmitted Kala-azar in India","volume":"36","author":"Singh","year":"1996","journal-title":"Transfusion"},{"key":"10.1007\/s10156-004-0348-9_bib0050","doi-asserted-by":"crossref","first-page":"435","DOI":"10.4269\/ajtmh.1991.45.435","article-title":"Comparison of regimes of treatment of antimony-resistant kala-azar patients: a randomized study","volume":"45","author":"Thakur","year":"1991","journal-title":"Am J Trop Med Hyg"},{"key":"10.1007\/s10156-004-0348-9_bib0055","series-title":"Proceedings of round table conference series No. 5.","first-page":"27","article-title":"Drug resistance in kala-azar: an overviews","author":"Thakur","year":"1999"},{"key":"10.1007\/s10156-004-0348-9_bib0060","doi-asserted-by":"crossref","first-page":"296","DOI":"10.4269\/ajtmh.1992.46.296","article-title":"Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies","volume":"46","author":"Herwaldt","year":"1992","journal-title":"Am J Trop Med Hyg"},{"key":"10.1007\/s10156-004-0348-9_bib0065","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1093\/clind\/24.4.684","article-title":"Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years","volume":"24","author":"Berman","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1007\/s10156-004-0348-9_bib0070","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/clinids\/18.1.83","article-title":"Pancreatitis induced by pentavalent antimonial agents during treatment of leishmaniasis","volume":"18","author":"Gasser","year":"1994","journal-title":"Clin Infect Dis"},{"key":"10.1007\/s10156-004-0348-9_bib0075","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1093\/clinids\/22.5.878","article-title":"Reversible peripheral neuropathy associated with sodium stibogluconate therapy for American cutaneous leishmaniasis","volume":"22","author":"Brummitt","year":"1996","journal-title":"Clin Infect Dis"},{"key":"10.1007\/s10156-004-0348-9_bib0080","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0035-9203(83)90058-5","article-title":"Evaluation of diamidine compound (pentamidine isethionate) in the treatment resistant cases of kala-azar occurring in North Bihar India","volume":"77","author":"Jha","year":"1983","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1007\/s10156-004-0348-9_bib0085","first-page":"314","article-title":"Changing response to diamidine compounds in cases of kala-azar unresponsive to antimonial","volume":"39","author":"Jha","year":"1991","journal-title":"J Assoc Physicians India"},{"key":"10.1007\/s10156-004-0348-9_bib0090","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4269\/ajtmh.1994.50.107","article-title":"Successful treatment of Colombian cutaneous leishmaniasis with four injections of pentamidine","volume":"50","author":"Soto","year":"1994","journal-title":"Am J Trop Med Hyg"},{"key":"10.1007\/s10156-004-0348-9_bib0095","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s004300100088","article-title":"Treatment of visceral leishmaniasis","volume":"190","author":"Sundar","year":"2001","journal-title":"Med Microbiol Immunol (Berl)"},{"issue":"8830","key":"10.1007\/s10156-004-0348-9_bib0100","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/0140-6736(92)92952-C","article-title":"Amphotericin versus pentamidine in antimony-unresponsive kala-azar","volume":"340","author":"Mishra","year":"1992","journal-title":"Lancet"},{"key":"10.1007\/s10156-004-0348-9_bib0105","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF02860503","article-title":"Efficacy of amphotericin B in multi-drug resistant kala-azar in children in first decade of life","volume":"60","author":"Thakur","year":"1993","journal-title":"Indian J Pediatr"},{"issue":"8937","key":"10.1007\/s10156-004-0348-9_bib0110","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/S0140-6736(94)90406-5","article-title":"Amphotericin versus sodium stibogluconate in first-line treatment of Indian kala-azar","volume":"344","author":"Mishra","year":"1994","journal-title":"Lancet"},{"key":"10.1007\/s10156-004-0348-9_bib0115","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/clinids\/19.3.560","article-title":"Relapse of visceral leishmaniasis in patients who were coinfected with human immunodeficiency virus and who received treatment with liposomal amphotericin B","volume":"19","author":"Davidson","year":"1994","journal-title":"Clin Infect Dis"},{"key":"10.1007\/s10156-004-0348-9_bib0120","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/clinids\/21.1.188","article-title":"Liposomal amphotericin B (AmBisome) in the treatment of complicated kala-azar under field conditions","volume":"21","author":"Seaman","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1007\/s10156-004-0348-9_bib0125","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1093\/infdis\/173.5.1208","article-title":"Phase I study of amphotericin B colloidal dispersion for the treatment of invasive fungal infections after marrow transplant","volume":"173","author":"Bowden","year":"1996","journal-title":"J Infect Dis"},{"key":"10.1007\/s10156-004-0348-9_bib0130","doi-asserted-by":"crossref","first-page":"133","DOI":"10.7326\/0003-4819-127-2-199707150-00007","article-title":"Short course low\u2013dose amphotericin B lipid complex therapy for visceral leishmaniasis unresponsive to antimony","volume":"127","author":"Sundar","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1007\/s10156-004-0348-9_bib0135","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0035-9203(90)90263-E","article-title":"Treatment of visceral leishmaniasis in Kenya by aminosidine alone or combined with sodium stibogluconate","volume":"84","author":"Chunge","year":"1990","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1007\/s10156-004-0348-9_bib0140","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/0035-9203(92)90151-2","article-title":"Aminosidine (paromomycin) in the treatment of leishmaniasis imported into the United Kingdom","volume":"86","author":"Scott","year":"1992","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"1","key":"10.1007\/s10156-004-0348-9_bib0145","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1056\/NEJM199001043220104","article-title":"Treatment of visceral leishmaniasis with pentavalent antimony and interferon gamma","volume":"322","author":"Badaro","year":"1990","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1007\/s10156-004-0348-9_bib0150","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1093\/infdis\/172.6.1627","article-title":"Effect of treatment with interferon-gamma alone in visceral leishmaniasis","volume":"172","author":"Sundar","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1007\/s10156-004-0348-9_bib0155","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S1201-9712(00)90110-3","article-title":"Hepatitis B and C viral infections in Indian kala-azar patients receiving injectable antileishmanial drugs: a community-based study","volume":"4","author":"Singh","year":"2000","journal-title":"Int J Infect Dis"},{"key":"10.1007\/s10156-004-0348-9_bib0160","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1136\/bmj.291.6509.1611","article-title":"Metronidazole and Indian kala-azar: results of a clinical trial","volume":"291","author":"Mishra","year":"1985","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1007\/s10156-004-0348-9_bib0165","first-page":"383","article-title":"Inefficacy of ethambutol, ethambutol plus isoniazid, INH plus rifampicin, co-trimoxazole and metronidazole in the treatment of kala-azar","volume":"92","author":"Thakur","year":"1989","journal-title":"Am J Trop Med Hyg"},{"key":"10.1007\/s10156-004-0348-9_bib0170","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/0035-9203(83)90071-8","article-title":"Evaluation of Allopurinol in treatment of kala-azar occurring in North Bihar India","volume":"77","author":"Jha","year":"1983","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1007\/s10156-004-0348-9_bib0175","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1111\/j.1365-2133.1987.tb07504.x","article-title":"Ketoconazole in cutaneous leishmaniasis","volume":"117","author":"Weinrauch","year":"1987","journal-title":"Br J Dermatol"},{"key":"10.1007\/s10156-004-0348-9_bib0180","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/0035-9203(90)90028-D","article-title":"The use of itraconazole in the treatment of leishmaniasis caused by Leishmania aethiopica","volume":"84","author":"Akuffo","year":"1990","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1007\/s10156-004-0348-9_bib0185","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/infdis\/166.1.215","article-title":"Ketoconazole in the treatment of antimony- and pentamidine-resistant kala-azar","volume":"166","author":"Wali","year":"1992","journal-title":"J Infect Dis"},{"issue":"9027","key":"10.1007\/s10156-004-0348-9_bib0190","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S0140-6736(05)64828-3","article-title":"Treatment of kala-azar with oral fluconazole","volume":"348","author":"Sundar","year":"1996","journal-title":"Lancet"},{"key":"10.1007\/s10156-004-0348-9_bib0195","doi-asserted-by":"crossref","first-page":"685","DOI":"10.4269\/ajtmh.2001.65.685","article-title":"Phase 2 trial of WR6026, an orally administered 8- aminoquinoline, in the treatment of visceral leishmaniasis caused by Leishmania chagasi","volume":"65","author":"Dietze","year":"2001","journal-title":"Am J Trop Med Hyg"},{"key":"10.1007\/s10156-004-0348-9_bib0200","doi-asserted-by":"crossref","first-page":"26336","DOI":"10.1016\/0006-2952(87)90543-0","article-title":"The activity of alkyl phosphorylcholines and related compounds against Leishmania donovani","volume":"36","author":"Croft","year":"1987","journal-title":"Biochem Pharmacol"},{"key":"10.1007\/s10156-004-0348-9_bib0205","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1093\/jac\/38.6.1041","article-title":"The activities of four anticancer alkyl-phospholipids against Leishmania donovani Trypanosoma cruzi and Trypanosoma brucei","volume":"38","author":"Croft","year":"1996","journal-title":"J Antimicrob Chemother"},{"key":"10.1007\/s10156-004-0348-9_bib0210","first-page":"185","article-title":"Alkylphosphocholine in visceral leishmaniasis: in-vitro and in-vivo study","volume":"20","author":"Singh","year":"1996","journal-title":"J Parasit Dis"},{"issue":"24","key":"10.1007\/s10156-004-0348-9_bib0215","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1056\/NEJM199912093412403","article-title":"Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis","volume":"341","author":"Jha","year":"1999","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1007\/s10156-004-0348-9_bib0220","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1056\/NEJMoa021556","article-title":"Oral miltefosine for Indian visceral leishmaniasis","volume":"347","author":"Sundar","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1007\/s10156-004-0348-9_bib0225","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2174\/1381612023396258","article-title":"Chemotherapy of leishmaniasis","volume":"8","author":"Croft","year":"2002","journal-title":"Curr Pharm Des"},{"key":"10.1007\/s10156-004-0348-9_bib0230","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4103\/0022-3859.926","article-title":"Recent understanding in the treatment of visceral leishmaniasis","volume":"49","author":"Rosenthal","year":"2003","journal-title":"J Postgrad Med"},{"key":"10.1007\/s10156-004-0348-9_bib0235","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1128\/AAC.42.3.654","article-title":"Short- and long-term efficacy of hexadecylphosphocholine against established Leishmania infantum infection in BALB\/c mice","volume":"42","author":"Le Fichoux","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1007\/s10156-004-0348-9_bib0240","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S0924-8579(03)00125-0","article-title":"Characterization of Leishmania donovani promastigotes resistant to hexadecylphosphocholine (miltefosine)","volume":"22","author":"Seifert","year":"2003","journal-title":"Int J Antimicrob Agents"},{"issue":"2","key":"10.1007\/s10156-004-0348-9_bib0245","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/1523-1747.ep12696697","article-title":"Topical treatment of cutaneous leishmaniasis","volume":"87","author":"El-On","year":"1986","journal-title":"J Invest Dermatol"},{"key":"10.1007\/s10156-004-0348-9_bib0250","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/j.1365-4362.1993.tb05044.x","article-title":"Intralesional treatment of cutaneous leishmaniasis with sodium stibogluconate antimony","volume":"32","author":"Faris","year":"1993","journal-title":"Int J Dermatol"},{"key":"10.1007\/s10156-004-0348-9_bib0255","doi-asserted-by":"crossref","first-page":"92","DOI":"10.4269\/ajtmh.1991.45.92","article-title":"Placebo controlled treatment of Ecuadorian cutaneous leishmaniasis","volume":"45","author":"Guderian","year":"1991","journal-title":"Am J Trop Med Hyg"},{"key":"10.1007\/s10156-004-0348-9_bib0260","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1093\/clinids\/20.1.47","article-title":"Successful treatment of New World cutaneous leishmaniasis with a combination of topical paromomycin\/methylbenzethonium chloride and injectable meglumine antimonate","volume":"20","author":"Soto","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1007\/s10156-004-0348-9_bib0265","doi-asserted-by":"crossref","first-page":"162","DOI":"10.4269\/ajtmh.1995.53.162","article-title":"A randomized, placebo-controlled trial in Tunisia treating cutaneous leishmaniasis with paromomycin ointment","volume":"53","author":"Ben Salah","year":"1995","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"10.1007\/s10156-004-0348-9_bib0270","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/0035-9203(94)90308-5","article-title":"Treatment of \u201cOld World\u201d cutaneous leishmaniasis with aminosidine ointment: results of an open study in London","volume":"88","author":"Bryceson","year":"1994","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1007\/s10156-004-0348-9_bib0275","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s004300100086","article-title":"Current issues in the treatment of visceral leishmaniasis","volume":"190","author":"Bryceson","year":"2001","journal-title":"Med Microbiol Immunol"},{"key":"10.1007\/s10156-004-0348-9_bib0280","doi-asserted-by":"crossref","first-page":"466","DOI":"10.4269\/ajtmh.2001.65.466","article-title":"Randomized, controlled, double-blind trial of topical treatment of cutaneous leishmaniasis with paromomycin plus methylbenzethonium chloride ointment in Guatemala","volume":"65","author":"Arana","year":"2001","journal-title":"Am J Trop Med Hyg"},{"key":"10.1007\/s10156-004-0348-9_bib0285","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1128\/AAC.46.1.259-261.2002","article-title":"Combination therapy with indolylquinoline derivative and sodium antimony gluconate cures established visceral leishmaniasis in hamsters","volume":"46","author":"Pal","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1007\/s10156-004-0348-9_bib0290","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s004360050529","article-title":"The efficacy of pentamidine combined with allopurinol and immunotherapy for the treatment of patients with diffuse cutaneous leishmaniasis","volume":"85","author":"Becker","year":"1999","journal-title":"Parasitol Res"},{"key":"10.1007\/s10156-004-0348-9_bib0295","first-page":"609","article-title":"A randomized clinical trial of low dosage combination of pentamidine and allopurinol in the treatment of antimony unresponsive cases of visceral leishmaniasis","volume":"49","author":"Das","year":"2001","journal-title":"J Assoc Physicians India"},{"issue":"11","key":"10.1007\/s10156-004-0348-9_bib0300","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S1473-3099(04)01179-X","article-title":"Mucosal Leishmaniasis in an Indian AIDS patient","volume":"4","author":"Singh","year":"2004","journal-title":"Lancet Infect DIS"},{"issue":"suppl 1","key":"10.1007\/s10156-004-0348-9_bib0305","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1179\/000349803225002624","article-title":"Clinical survey of leishmania\/HIV co-infection in Catania Italy: the impact of highly active antiretroviral therapy (HAART)","volume":"97","author":"Russo","year":"2003","journal-title":"Ann Trop Med Parasitol"},{"issue":"9","key":"10.1007\/s10156-004-0348-9_bib0310","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1086\/344325","article-title":"Impact of highly active antiretroviral therapy on the incidence of visceral leishmaniasis in a French cohort of patients infected with human immunodeficiency virus","volume":"186","author":"del Giudice","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1007\/s10156-004-0348-9_bib0315","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/00126334-200207010-00015","article-title":"Highly active antiretroviral therapy (HAART) modifies the incidence and outcome of visceral leishmaniasis in HIV-infected patients","volume":"30","author":"Tortajada","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3","key":"10.1007\/s10156-004-0348-9_bib0320","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1093\/nar\/30.3.794","article-title":"An insight into the active site of a type I DNA topoisomerase from the kinetoplastid protozoan Leishmania donovani","volume":"30","author":"Das","year":"2002","journal-title":"Nucleic Acids Res"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X04710284?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X04710284?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s10156-004-0348-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:43:47Z","timestamp":1761158627000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X04710284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004]]},"references-count":64,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004]]}},"alternative-id":["S1341321X04710284"],"URL":"https:\/\/doi.org\/10.1007\/s10156-004-0348-9","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2004]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Challenges and new discoveries in the treatment of leishmaniasis","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s10156-004-0348-9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Japanese Society of Chemotherapy and the Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}